A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial (Q48068592)
Jump to navigation
Jump to search
scientific article published on 10 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial |
scientific article published on 10 August 2014 |
Statements
1 reference
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Elaine M Pascoe
1 reference
Stephen P McDonald
1 reference
Alicia T Morrish
1 reference
Eugenie Pedagogos
1 reference
Anish Scaria
1 reference
Rowan Walker
1 reference
Liza A Vergara
1 reference
HERO Study Collaborative Group
1 reference
10 August 2014
1 reference
65
1 reference
1
1 reference
49-57
1 reference
Identifiers
1 reference